Justine Telliez
Stock Analyst at Kepler Capital
(4.93)
# 187
Out of 5,004 analysts
354
Total ratings
53.7%
Success rate
60.1%
Average return
Main Sectors:
Stocks Rated by Justine Telliez
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: DBV DBV Technologies S.A. | Reiterated: Buy | €5.50 | €2.02 | +172.01% | 26 | May 4, 2026 | |
| EPA: GBT Guerbet SA | Reiterated: Hold | €13.80 | €7.03 | +96.30% | 24 | Apr 24, 2026 | |
| BIT: PHIL Philogen S.p.A. | Reiterated: Buy | €34.00 | €22.60 | +50.44% | 1 | Apr 24, 2026 | |
| SWX: GALD Galderma Group AG | Reiterated: Buy | CHF 167.00 | CHF 163.00 | +2.45% | 12 | Apr 23, 2026 | |
| EPA: ADOC Adocia SA | Reiterated: Buy | €12.00 | €2.62 | +358.02% | 26 | Apr 22, 2026 | |
| EPA: IPN Ipsen S.A. | Reiterated: Hold | €132.00 | €143.30 | -7.89% | 35 | Apr 22, 2026 | |
| EPA: ABVX ABIVAX Société Anonyme | Reiterated: Buy | €130.00 | €81.90 | +58.73% | 33 | Apr 13, 2026 | |
| EPA: SIGHT GenSight Biologics S.A. | Reiterated: Hold | €0.40 | €0.12 | +225.73% | 31 | Apr 8, 2026 | |
| EPA: GNFT Genfit S.A. | Reiterated: Buy | €15.00 | €8.92 | +68.16% | 42 | Apr 7, 2026 | |
| SWX: IDIA Idorsia Ltd | Reiterated: Buy | CHF 4.50 | CHF 4.44 | +1.40% | 36 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €7.70 → €5.60 | €2.66 | +110.53% | 63 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €3.10 | €1.44 | n/a | 24 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.30 | €1.13 | n/a | 1 | Dec 1, 2023 |
DBV Technologies S.A.
May 4, 2026
Reiterated: Buy
Price Target: €5.50
Current: €2.02
Upside: +172.01%
Guerbet SA
Apr 24, 2026
Reiterated: Hold
Price Target: €13.80
Current: €7.03
Upside: +96.30%
Philogen S.p.A.
Apr 24, 2026
Reiterated: Buy
Price Target: €34.00
Current: €22.60
Upside: +50.44%
Galderma Group AG
Apr 23, 2026
Reiterated: Buy
Price Target: CHF 167.00
Current: CHF 163.00
Upside: +2.45%
Adocia SA
Apr 22, 2026
Reiterated: Buy
Price Target: €12.00
Current: €2.62
Upside: +358.02%
Ipsen S.A.
Apr 22, 2026
Reiterated: Hold
Price Target: €132.00
Current: €143.30
Upside: -7.89%
ABIVAX Société Anonyme
Apr 13, 2026
Reiterated: Buy
Price Target: €130.00
Current: €81.90
Upside: +58.73%
GenSight Biologics S.A.
Apr 8, 2026
Reiterated: Hold
Price Target: €0.40
Current: €0.12
Upside: +225.73%
Genfit S.A.
Apr 7, 2026
Reiterated: Buy
Price Target: €15.00
Current: €8.92
Upside: +68.16%
Idorsia Ltd
Mar 30, 2026
Reiterated: Buy
Price Target: CHF 4.50
Current: CHF 4.44
Upside: +1.40%
Mar 26, 2026
Reiterated: Buy
Price Target: €7.70 → €5.60
Current: €2.66
Upside: +110.53%
May 23, 2025
Reiterated: Hold
Price Target: €3.10
Current: €1.44
Upside: n/a
Dec 1, 2023
Reiterated: Buy
Price Target: €16.30
Current: €1.13
Upside: n/a